Search
Categories
Hot topics close

Biogen to halt late-stage trial of promising Alzheimer's drug

US pharmaceuticals company Biogen and its Japanese partner Eisai have announced they will cease clinical trials for a promising Alzheimer's disease treatment, sending shares in Biogen tumbling by a quarter. Nasdaq-listed Biogen and Tokyo-listed Eisai 
Similar news
News Archive
  • Flair
    Flair
    Video: Ric Flair And Jay Lethal Practice In The Ring Together
    18 Apr 2022
    2
  • OTC Markets Group
    OTC Markets Group
    Serve Robotics Inc. Common Stock to Be Quoted on OTCQB Under Ticker Symbol "SBOT"
    12 Mar 2024
    2
  • Chi Chi DeVayne
    Chi Chi DeVayne
    RuPaul's Drag Race Fans Moved To Tears By Beautiful Chi Chi DeVayne Tribute
    24 Apr 2021
    9
This week's most popular news